What are the indications and benchmarks for titrating and weaning critically ill patients from hydromorphone continuous IV infusion?
Titrating and weaning hydromorphone in critically ill patients should emphasize individualized dosing, gradual adjustments, and consistent monitoring to prevent adverse effects and withdrawal symptoms. Evidence remains partly limited to broader opioid management practices rather than specific hydromorphone protocols.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-04
- DOI
- https://doi.org/10.5281/zenodo.23953921
- Primary Topic
- Pain Management and Opioid Use
- Type
- article
- Field-Weighted Citation Impact
- 0.00